Old asthma drug shows promise for rare genetic disorder
NCT ID NCT04240821
First seen Nov 12, 2025 · Last updated May 02, 2026 · Updated 25 times
Summary
This study tests whether theophylline, a drug used for asthma, can help people with pseudohypoparathyroidism, a rare genetic condition causing early obesity, short stature, and hormone problems. About 34 children and young adults who completed a prior trial will take the drug to see if it leads to weight loss and better hormone balance. The main focus is safety and changes in body mass index.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSEUDOHYPOPARATHYROIDISM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
Conditions
Explore the condition pages connected to this study.